Clinical Trial Update: A Study of Lutetium [177Lu]-BL-ARC001 in Patients With Locally Advanced or Metastatic Lung Cancer, Breast Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors [Phase 1]

View source ↗

Summary

This is an update on an ongoing Phase 1 clinical trial evaluating Lutetium-177Lu-BL-ARC001 in patients with lung cancer, breast cancer, and head and neck squamo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Head and Neck Squamous Cell Carcinoma
• Lung Cancer

Drugs mentioned

• Lutetium-177Lu BL-ARC001 (BL-ARC001)

Snippet

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Conditions: Lung Cancer, Breast Cancer | Phase 1 | Status: RECRUITING